Susquehanna International Group
LSTA icon

Susquehanna International Group’s Lisata Therapeutics LSTA Stock Holding History

Susquehanna International Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1K Buy
+11,604
New +$47.9K ﹤0.01% 12596
2024
Q4 		– Sell
-11,019
Closed -$33.1K – 12784
2024
Q3 		$33.1K Buy
+11,019
New +$34.7K ﹤0.01% 11512
2024
Q2 		– Sell
-10,719
Closed -$33.4K – 12741
2024
Q1 		$33.4K Sell
10,719
-23,030
-68% -$68.2K ﹤0.01% 11685
2023
Q4 		$92.1K Buy
+33,749
New +$79.2K ﹤0.01% 11393
2022
Q3 		– Sell
-864
Closed -$6.26K – 13740
2022
Q2 		$7K Sell
864
-1,736
-67% -$14.3K ﹤0.01% 12570
2022
Q1 		$28K Buy
2,600
+1,022
+65% +$11.7K ﹤0.01% 12531
2021
Q4 		$20K Sell
1,578
-15,537
-91% -$240K ﹤0.01% 12826
2021
Q3 		$313K Buy
17,115
+15,971
+1,396% +$313K ﹤0.01% 10508
2021
Q2 		$28K Sell
1,144
-5,674
-83% -$134K ﹤0.01% 12392
2021
Q1 		$197K Buy
6,818
+5,372
+372% +$163K ﹤0.01% 11436
2020
Q4 		$31K Sell
1,446
-2,779
-66% -$66K ﹤0.01% 10838
2020
Q3 		$114K Buy
+4,225
New +$134K ﹤0.01% 9839
2020
Q1 		– Sell
-1,363
Closed -$51K – 10612
2019
Q4 		$51K Buy
+1,363
New +$49K ﹤0.01% 9339
2017
Q1 		– Sell
-728
Closed -$31K – 9513
2016
Q4 		$31K Buy
+728
New +$41.8K ﹤0.01% 9372
2016
Q1 		– Sell
-208
Closed -$34K – 9388
2015
Q4 		$34K Sell
208
-224
-52% -$41.1K ﹤0.01% 9164
2015
Q3 		$97K Sell
432
-1,358
-76% -$341K ﹤0.01% 9154
2015
Q2 		$502K Buy
1,790
+1,240
+225% +$461K ﹤0.01% 7630
2015
Q1 		$210K Sell
550
-119
-18% -$64.5K ﹤0.01% 8568
2014
Q4 		$378K Buy
669
+381
+132% +$259K ﹤0.01% 7749
2014
Q3 		$239K Sell
288
-36
-11% -$31.5K ﹤0.01% 8370
2014
Q2 		$317K Buy
324
+66
+26% +$64.2K ﹤0.01% 8278
2014
Q1 		$273K Buy
258
+59
+30% +$64K ﹤0.01% 7734
2013
Q4 		$204K Buy
+199
New +$197K ﹤0.01% 8238

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's LSTA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Lisata Therapeutics (LSTA) in Q1 2026: 11,604 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #12596 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in LSTA as recently as Q3 2024.

Susquehanna International Group first reported a position in LSTA in Q4 2013 and has held it in 23 quarters since. The position peaked at $502K in Q2 2015. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Susquehanna International Group held 11,604 shares of Lisata Therapeutics worth $58.1K as of Q1 2026.
  • Lisata Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12596 holding.
  • Susquehanna International Group first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 23 quarters since.
  • Susquehanna International Group's Lisata Therapeutics position peaked at $502K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.